Cargando…

Amide proton transfer-weighted magnetic resonance imaging for the diagnosis of symptomatic chronic intracranial artery stenosis: a feasibility study

BACKGROUND: Hemodynamic changes after intracranial artery stenosis (ICAS) or occlusion are important causes of metabolic alterations in tissue. This study aimed to explore the feasibility of using amide proton transfer-weighted (APTw) magnetic resonance imaging (MRI) to diagnose patients with sympto...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kunjian, Dou, Weiqiang, Mao, Huimin, Wang, Xinyu, Wang, Xinyi, Guo, Yu, Zhang, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622450/
https://www.ncbi.nlm.nih.gov/pubmed/36330191
http://dx.doi.org/10.21037/qims-21-1063
_version_ 1784821771196694528
author Chen, Kunjian
Dou, Weiqiang
Mao, Huimin
Wang, Xinyu
Wang, Xinyi
Guo, Yu
Zhang, Chao
author_facet Chen, Kunjian
Dou, Weiqiang
Mao, Huimin
Wang, Xinyu
Wang, Xinyi
Guo, Yu
Zhang, Chao
author_sort Chen, Kunjian
collection PubMed
description BACKGROUND: Hemodynamic changes after intracranial artery stenosis (ICAS) or occlusion are important causes of metabolic alterations in tissue. This study aimed to explore the feasibility of using amide proton transfer-weighted (APTw) magnetic resonance imaging (MRI) to diagnose patients with symptomatic chronic ICAS based on pH variations caused by metabolite damage. METHODS: Sixty-seven patients with clinically confirmed unilateral anterior circulation ICAS (≥70% arterial narrowing) and 20 healthy volunteers were recruited for the study. Each patient underwent an MRI examination including a T2 fluid-attenuated inversion recovery (T2-FLAIR) sequence, spin-echo echo-planar diffusion-weighted imaging (DWI), three-dimensional pseudo-continuous arterial spin labeling (pcASL), and an APTw sequence. Areas with abnormal perfusion and APTw effects were defined as perfusion/pH matched areas; areas with abnormal perfusion but normal APTw effects were defined as perfusion/pH unmatched areas; the contralateral mirror areas were defined as the normal areas. Regions of interest (ROIs) were selected within these three areas, and the corresponding apparent diffusion coefficient (ADC), cerebral blood flow (CBF), and magnetization transfer ratio asymmetry (MTR(asym)) were measured. RESULTS: High intraclass correlation coefficient (ICC) values (0.78≤ ICCs ≤0.97; P<0.05) were observed between the two radiologists who independently performed the data analysis. Significant differences were found in CBF and MTR(asym) between the perfusion/pH matched, perfusion/pH unmatched, and normal areas [F((2,64))=288.5, 163.5; both P<0.05], but the ADC values were comparable between the three [F((2,64))=2.11; P>0.05]. Spearman correlation analysis revealed no significant correlation between changes in MTR(asym) and CBF (P>0.05). Finally, APTw showed a robust performance in diagnosing symptomatic chronic ICAS, with an area under the receiver operating characteristic curve (ROC) of 0.953 (sensitivity 97.01%; specificity 85.07%; cut-off value 1.005%). CONCLUSIONS: The present study has demonstrated that metabolic alterations are present in patients with symptomatic chronic ICAS. Our findings illustrate that APTw imaging could potentially serve as an effective method to provide a robust clinical diagnosis for patients with symptomatic chronic ICAS.
format Online
Article
Text
id pubmed-9622450
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-96224502022-11-02 Amide proton transfer-weighted magnetic resonance imaging for the diagnosis of symptomatic chronic intracranial artery stenosis: a feasibility study Chen, Kunjian Dou, Weiqiang Mao, Huimin Wang, Xinyu Wang, Xinyi Guo, Yu Zhang, Chao Quant Imaging Med Surg Original Article BACKGROUND: Hemodynamic changes after intracranial artery stenosis (ICAS) or occlusion are important causes of metabolic alterations in tissue. This study aimed to explore the feasibility of using amide proton transfer-weighted (APTw) magnetic resonance imaging (MRI) to diagnose patients with symptomatic chronic ICAS based on pH variations caused by metabolite damage. METHODS: Sixty-seven patients with clinically confirmed unilateral anterior circulation ICAS (≥70% arterial narrowing) and 20 healthy volunteers were recruited for the study. Each patient underwent an MRI examination including a T2 fluid-attenuated inversion recovery (T2-FLAIR) sequence, spin-echo echo-planar diffusion-weighted imaging (DWI), three-dimensional pseudo-continuous arterial spin labeling (pcASL), and an APTw sequence. Areas with abnormal perfusion and APTw effects were defined as perfusion/pH matched areas; areas with abnormal perfusion but normal APTw effects were defined as perfusion/pH unmatched areas; the contralateral mirror areas were defined as the normal areas. Regions of interest (ROIs) were selected within these three areas, and the corresponding apparent diffusion coefficient (ADC), cerebral blood flow (CBF), and magnetization transfer ratio asymmetry (MTR(asym)) were measured. RESULTS: High intraclass correlation coefficient (ICC) values (0.78≤ ICCs ≤0.97; P<0.05) were observed between the two radiologists who independently performed the data analysis. Significant differences were found in CBF and MTR(asym) between the perfusion/pH matched, perfusion/pH unmatched, and normal areas [F((2,64))=288.5, 163.5; both P<0.05], but the ADC values were comparable between the three [F((2,64))=2.11; P>0.05]. Spearman correlation analysis revealed no significant correlation between changes in MTR(asym) and CBF (P>0.05). Finally, APTw showed a robust performance in diagnosing symptomatic chronic ICAS, with an area under the receiver operating characteristic curve (ROC) of 0.953 (sensitivity 97.01%; specificity 85.07%; cut-off value 1.005%). CONCLUSIONS: The present study has demonstrated that metabolic alterations are present in patients with symptomatic chronic ICAS. Our findings illustrate that APTw imaging could potentially serve as an effective method to provide a robust clinical diagnosis for patients with symptomatic chronic ICAS. AME Publishing Company 2022-11 /pmc/articles/PMC9622450/ /pubmed/36330191 http://dx.doi.org/10.21037/qims-21-1063 Text en 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Chen, Kunjian
Dou, Weiqiang
Mao, Huimin
Wang, Xinyu
Wang, Xinyi
Guo, Yu
Zhang, Chao
Amide proton transfer-weighted magnetic resonance imaging for the diagnosis of symptomatic chronic intracranial artery stenosis: a feasibility study
title Amide proton transfer-weighted magnetic resonance imaging for the diagnosis of symptomatic chronic intracranial artery stenosis: a feasibility study
title_full Amide proton transfer-weighted magnetic resonance imaging for the diagnosis of symptomatic chronic intracranial artery stenosis: a feasibility study
title_fullStr Amide proton transfer-weighted magnetic resonance imaging for the diagnosis of symptomatic chronic intracranial artery stenosis: a feasibility study
title_full_unstemmed Amide proton transfer-weighted magnetic resonance imaging for the diagnosis of symptomatic chronic intracranial artery stenosis: a feasibility study
title_short Amide proton transfer-weighted magnetic resonance imaging for the diagnosis of symptomatic chronic intracranial artery stenosis: a feasibility study
title_sort amide proton transfer-weighted magnetic resonance imaging for the diagnosis of symptomatic chronic intracranial artery stenosis: a feasibility study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622450/
https://www.ncbi.nlm.nih.gov/pubmed/36330191
http://dx.doi.org/10.21037/qims-21-1063
work_keys_str_mv AT chenkunjian amideprotontransferweightedmagneticresonanceimagingforthediagnosisofsymptomaticchronicintracranialarterystenosisafeasibilitystudy
AT douweiqiang amideprotontransferweightedmagneticresonanceimagingforthediagnosisofsymptomaticchronicintracranialarterystenosisafeasibilitystudy
AT maohuimin amideprotontransferweightedmagneticresonanceimagingforthediagnosisofsymptomaticchronicintracranialarterystenosisafeasibilitystudy
AT wangxinyu amideprotontransferweightedmagneticresonanceimagingforthediagnosisofsymptomaticchronicintracranialarterystenosisafeasibilitystudy
AT wangxinyi amideprotontransferweightedmagneticresonanceimagingforthediagnosisofsymptomaticchronicintracranialarterystenosisafeasibilitystudy
AT guoyu amideprotontransferweightedmagneticresonanceimagingforthediagnosisofsymptomaticchronicintracranialarterystenosisafeasibilitystudy
AT zhangchao amideprotontransferweightedmagneticresonanceimagingforthediagnosisofsymptomaticchronicintracranialarterystenosisafeasibilitystudy